Tane, Shinya https://orcid.org/0000-0003-3747-5088
Nishikubo, Megumi
Manabe, Takehiko
Watanabe, Takuya
Nomura, Kotaro
Hamada, Akira
Takamori, Shinkichi
Katsumata, Shinya
Shimizu, Nahoko
Kojima, Hideaki
Takamori, Satoshi
Muto, Satoshi
Abe, Miyuki
Yoshikawa, Mao
Suzuki, Jun
Toda, Michihito
Okada, Satoru
Kano, Shu
Ohde, Yasuhisa
Maniwa, Yoshimasa
Article History
Received: 17 December 2025
Accepted: 4 February 2026
First Online: 26 February 2026
Disclosure
: Takuya Watanabe engaged in relevant financial activities outside the submitted work for MSD K.K., Chugai Pharmaceutical Co., AstraZeneca K.K., and Ono Pharmaceutical Co. Akira Hamada-Chugai Pharmaceutical Co., Ltd.; received research funding, honoraria, and advisory fees from AstraZeneca K.K. and Ono Pharmaceutical Co., Ltd.; received honoraria from Bristol-Myers Squibb K.K. Ethicon Japan K.K., Medtronic Japan Co., Ltd., MSD K.K., Satoshi Muto, AstraZeneca K.K., and Chugai Pharm. Michihito Toda; and received lecture fees from AstraZeneca K.K., Chugai Pharmaceutical Co., Ltd., Bristol Myers Squibb K.K., and Taiho Pharmaceutical Co., Ltd., MSD K.K. The remaining authors have no conflicts of interest.